Microbot Medical Inc (MBOT)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $65.73M
Last updated: Nov 17, 2026 at 4:43 PM ET
Microbot Medical Inc (MBOT) Statistics
Microbot Medical (MBOT) has a market cap of $65.73M and an enterprise value of $62.58M. It kept -4722.25% of revenue as net income over the last 12 months. Its share count is up 84.07% from a year earlier.
Total Valuation
Enterprise value is 4.80% below the market cap, as cash exceeds debt.
| Market Cap | $65.73M |
|---|---|
| Enterprise Value | $62.58M |
| Latest price (Nov 17, 2026) | $0.69 |
Key Dates
The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 133.7x and 0.7x.
| P/S Ratio | 133.7x |
|---|---|
| Forward P/S | 51.6x |
| P/B Ratio | 0.7x |
Price Statistics
The stock is down 66.72% over 52 weeks and trades 38.94% below its 50-day average.
| Beta (1Y) | 2.00 |
|---|---|
| 52-Week Change | -66.72% |
| 1-Month Change | -27.69% |
| 3-Month Change | -55.55% |
| 6-Month Change | -60.17% |
| 5-Year Change | -84.92% |
| 10-Year Change | -90.67% |
| Total Return (1Y) | -66.71% |
| Total Return (3Y CAGR) | -20.66% |
| Total Return (5Y CAGR) | -34.96% |
| Max Drawdown (1Y) | -77.39% |
| Max Drawdown (3Y) | -85.68% |
| Sharpe Ratio (1Y) | -1.34 |
| Correlation with SPY (1Y) | 0.35 |
| 50-Day Average | $1.13 |
| 200-Day Average | $1.79 |
| 52-Week Range | $0.52 to $2.85 |
| RSI (14 Days) | 28.8 |
| Average Volume (20 Days) | 1.46M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 18.56x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 18.56x |
|---|---|
| Quick Ratio | 17.82x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -23.70% and return on assets is -22.27% over the last 12 months.
| Return on Equity (ROE) | -23.70% |
|---|---|
| Return on Assets (ROA) | -22.27% |
| Asset Turnover | 0.01x |
| Inventory Turnover | 0.38x |
| Receivables Turnover | 2.46x |
| Cash Conversion Cycle | 741 days |
Scores
MBOT has an Altman Z-Score of 4.38, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.38 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $346.00K over the last 12 months is up 311.90% from the 12 months before.
| Revenue | $346.00K |
|---|---|
| Revenue Growth (YoY) | +311.90% |
| Gross Profit | -$651.00K |
| Operating Income | -$18.51M |
| Pretax Income | -$16.34M |
| Net Income | -$16.34M |
| Reported EPS (TTM) | -$0.26 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 93.96% of the $73.36M in total assets.
| Cash and Equivalents | $3.15M |
|---|---|
| Total Debt | $0 |
| Net Cash | $3.15M |
| Net Cash Per Share | $0.05 |
| Working Capital | $68.28M |
| Shareholder Equity | $68.93M |
| Book Value Per Share | $1.03 |
| Total Assets | $73.36M |
| Total Liabilities | $4.44M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $288.00K of capital spending, operating cash flow left -$17.93M of free cash flow.
| Operating Cash Flow | -$17.64M |
|---|---|
| Capital Expenditures | $288.00K |
| Free Cash Flow | -$17.93M |
| FCF Per Share | -$0.27 |
| Depreciation and Amortization | $47.00K |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -5348.84%.
| Gross Margin | -188.15% |
|---|---|
| Operating Margin | -5348.84% |
| Pretax Margin | -4722.25% |
| Net Margin | -4722.25% |
| FCF Margin | -5181.79% |
Growth
| Book Value Per Share Growth (2Y CAGR) | +76.40% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +76.40% |
Dividends and Yields
MBOT does not pay a dividend. Its free cash flow yield is -38.74%.
| FCF Yield | -38.74% |
|---|---|
| Buyback Yield | -116.04% |
| Shareholder Yield | -116.04% |
Stock Splits
The last split was a 1-for-15 reverse split on Sep 5, 2018.
| Last Split Date | Sep 5, 2018 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Peer Position
Against 12 similar companies, MBOT has the 2nd highest P/S.
P/S RatioPeer median 1.0x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.27%
| P/S Ratio | 133.7x vs 1.0x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +311.90% vs +9.27% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About MBOT
What is MBOT's market cap?
Microbot Medical has a market cap of $65.73M. Its enterprise value, which adds debt and subtracts cash, is $62.58M.
How many shares of MBOT are outstanding?
Microbot Medical has 67.16M shares outstanding. The count is up 84.07% from a year earlier.
Does MBOT pay a dividend?
No. Microbot Medical does not pay a dividend.
How much debt does MBOT have?
Microbot Medical has $0 of total debt and $3.15M of cash and equivalents, a net cash position of $3.15M.
MBOT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors